subsidiary has been restructured by set to work together. As a result, the cost of staff decreased, such as the cost of travel, commission fee as the overall revenue continues to increase. 3.4 Administration

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

this year, consequently, there was expenses related to the overseas travelling and other administration fees and (4) Decrease in tax and penalties due to the Company incurred tax and penalties provision

by 14% and 1% compared to Q2/2018 and Q1/2018, respectively. The Company and its subsidiary companies made a loss of THB 34 million in Q3/2018 or loss decreased by 69% compared to the same period at

the business environment by closed 8 departments which have accumulate loss in year 2019. Moreover the Company has promotional activity, made an advertisement in each area for increased sale

Co., Ltd. was decreased from Wuttisak Clinic was temporary closed from COVID - 19. 3.4 Administration expenses The Group's administrative expense was decreased from the same period of previous year in

standard of the state. The group also seeks the assurance from the government agency and has already received the Amazing Thailand Safety & Healthy Administration (SHA) standard from the Tourism Authority of

same period of 2021. Administrative Expenses In the 1st quarter of 2021, administration costs were THB 95.1 Mn, a decrease of THB 17.0 Mn or 15.2% from the same period of 2020. This decrease was mainly

which can meet efficiency the customer needs that made the Company got purchase order from large project in Quarter 1’ 2019 while in Quarter 1’ 2020 Thailand has scourged by Coronavirus disease (COVID-19